| Disease | multiple myeloma |
| Comorbidity | C1332362|b-cell neoplasm |
| Sentences | 1 |
| PubMedID- 22404949 | Although the clinical outcome of plasma cell myeloma when concomitant with other indolent b-cell neoplasms is unfavorable, our patient seemed to respond to high-dose bortezomib plus lenalidomide. |
Page: 1